CAR T-cell therapy is starting to enter the treatment conversations sooner with patients with multiple myeloma, according to ...

Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging ...

Background: Multiple myeloma (MM) is the second most common hematological malignancy that still lacks effective clinical treatments. In particular, MM with central nervous system (CNS) invasion occurs ...

Multiple myeloma causes lytic or osteolytic lesions, which are areas of damage caused by cancerous plasma cells blocking normal bone growth. While painful, they can be managed. Multiple myeloma is ...

Multiple people taken to hospital after crash near Fremont by: Katie Rosendale, A.J. Evans Posted: Jun 19, 2025 / 01:37 PM EDT Updated: Jun 20, 2025 / 05:09 AM EDT ...

PLYMOUTH TOWNSHIP, Pa. (CBS Philadelphia) — Police in Plymouth Township, Pennsylvania, are searching for drivers seen on camera doing donuts in a major intersection at a car meetup near the ...

Multiple myeloma (MM) is a form of blood cancer that originates from plasma cells – part of the white blood cell produced by the bone marrow responsible for providing the human body with the ...

The multiple myeloma treatment market is expected to undergo significant changes, with CAR-T therapies projected to capture 30% of the market in the long term. Given Arcellx’s strong clinical data and ...

Arcellx, part of the U.S. Small & Mid Cap Biotechnology sector, has emerged as a key player in the development of CAR-T therapies for multiple myeloma, a type of blood cancer.

“Cilta-cel is the first CAR T-cell therapy to show significant OS benefit in multiple myeloma, [with a] 45% reduction in the risk of death with cilta-cel vs SOC in patients with ...

Protein arginine methyltransferase 4 (PRMT4) is highly expressed in relapsed or refractory multiple myeloma (MM) and is associated with poor prognosis. Conventional PRMT4 inhibitors face challenges ...

Why? Because the automaker had to close multiple factories when China sought tariff revenge by limiting Ford’s supply of rare magnets. The automaker’s CEO finally went on record to reveal the current ...